SEC Form 4 · accession 0001543407-19-000025

BECTON DICKINSON & CO · BDX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP and Pres, Life Sciences

Period of report

Mar 4, 2019

Accepted (ET)

Mar 6, 2019 · 3:05 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000010795

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Mar 4, 2019	M	4,864	$108.89	A	22,476	D
Common Stock^F1	Mar 4, 2019	D	2,077	$255.03	D	20,399	D
Common Stock^F1	Mar 4, 2019	S	2,787	$255.03	D	17,612	D
Common Stock^F1	Mar 4, 2019	S	2,021	$255.03	D	15,591	D
Common Stock^F2	holding	—	—		—	2,554	I	GSIP Trust
Common Stock^F3	holding	—	—		—	1,055	I	SIP Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Appreciation Rights^F4	$108.89	Mar 4, 2019	M	4,864	D	Nov 26, 2014	Nov 26, 2023	Common Stock	4,864	3,483	D

F1The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $255 through $255.75. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.
F2Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of May 31, 2017.
F3Represents shares of common stock held under the Becton, Dickinson and Company Savings Incentive Plan (the "SIP"). The information presented for the SIP is as of July 31, 2017.
F4The stock appreciation rights vest in four annual installments beginning November 26, 2014.